Adeel Kaiser

Adeel Kaiser, M.D., is a board-certified radiation oncologist at Wertheim Cancer Institute and Co-Director of the Radiopharmaceutical Therapy Program. He has expertise in the treatment of a number of solid tumor malignancies, with a special focus on genitourinary and gastrointestinal cancers. He also has significant experience in proton therapy dating back to 2008, when he served as an assistant professor at Loma Linda University Medical Center, the first clinical proton therapy center in the United States. Dr. Kaiser joined Wertheim Cancer Institute in 2020 from the University of Maryland Department of Radiation Oncology, where he served as Fellowship Director as well as Director of the Integrative Wellness Program.

Adeel Kaiser, M.D., is a board-certified radiation oncologist at Wertheim Cancer Institute and Co-Director of the Radiopharmaceutical Therapy Program. He has expertise in the treatment of a number of solid tumor malignancies, with a special focus on genitourinary and gastrointestinal cancers. He also has significant experience in proton therapy dating back to 2008, when he served as an assistant professor at Loma Linda University Medical Center, the first clinical proton therapy center in the United States. Dr. Kaiser joined Wertheim Cancer Institute in 2020 from the University of Maryland Department of Radiation Oncology, where he served as Fellowship Director as well as Director of the Integrative Wellness Program.

Dr. McClure is a board-certified interventional radiologist and urologist whose expertise is focused on image-guided therapy and minimally invasive treatment of urologic disease. Dr. McClure is Director of Focal Therapy and Interventional Urology at Weill Cornell Medicine. His research interests include improved diagnosis and imaging for prostate cancer, focal therapy for prostate cancer, renal mass biopsy and ablation, and prostate artery embolization.

Adeel Kaiser, M.D., is a board-certified radiation oncologist at Wertheim Cancer Institute and Co-Director of the Radiopharmaceutical Therapy Program. He has expertise in the treatment of a number of solid tumor malignancies, with a special focus on genitourinary and gastrointestinal cancers. He also has significant experience in proton therapy dating back to 2008, when he served as an assistant professor at Loma Linda University Medical Center, the first clinical proton therapy center in the United States. Dr. Kaiser joined Wertheim Cancer Institute in 2020 from the University of Maryland Department of Radiation Oncology, where he served as Fellowship Director as well as Director of the Integrative Wellness Program.